STATE STREET CORP - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 90 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$2,746,181
-6.9%
1,596,617
+5.6%
0.00%
Q2 2023$2,949,057
+288.1%
1,512,337
+453.3%
0.00%
Q1 2023$759,857
-60.7%
273,330
-51.2%
0.00%
Q4 2022$1,934,278
+269.8%
560,660
+175.5%
0.00%
Q3 2022$523,000
-16.2%
203,530
-21.1%
0.00%
Q2 2022$624,000
-84.4%
257,830
-73.4%
0.00%
Q1 2022$3,996,000
-91.5%
969,982
-73.6%
0.00%
-100.0%
Q4 2021$47,245,000
+474.5%
3,673,779
+382.5%
0.00%
Q3 2021$8,224,000
+50.7%
761,474
+27.4%
0.00%
Q2 2021$5,456,000
+6.3%
597,641
+9.8%
0.00%
Q1 2021$5,131,000
+152.9%
544,122
+5.7%
0.00%
Q4 2020$2,029,000
+51.8%
514,882
+2.1%
0.00%
Q3 2020$1,337,000
-59.2%
504,378
+2.2%
0.00%
Q2 2020$3,277,000
+20.0%
493,516
+5.2%
0.00%
Q1 2020$2,730,000
-35.2%
469,112
-0.2%
0.00%
Q4 2019$4,215,000
+10.7%
469,950
+6.6%
0.00%
Q3 2019$3,808,000
-2.6%
441,012
+25.6%
0.00%
Q2 2019$3,910,000
+165.4%
351,030
+217.1%
0.00%
Q1 2019$1,473,000
+55.9%
110,715
+81.0%
0.00%
Q4 2018$945,00061,1600.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,102,929$18,059,047,0004.95%
Svennilson Peter 3,102,934$18,059,0002.29%
Casdin Capital, LLC 2,270,000$13,211,0001.40%
FRAZIER MANAGEMENT LLC 2,061,758$11,999,0001.36%
Redmile Group, LLC 3,068,194$17,857,0000.50%
Alphabet Inc. 929,022$5,407,0000.36%
Bleichroeder LP 169,039$984,0000.26%
Leap Investments LP 14,400$84,0000.12%
DAFNA Capital Management LLC 50,000$291,0000.12%
Blackstone Inc. 2,567,445$14,943,0000.11%
View complete list of GRITSTONE ONCOLOGY INC shareholders